Vadodara, Gujarat, India5 years of experience0 Patient StoriesEnglish, Hindi, Amharic
Dr. Ayush Nigam is a verified specialist on HealthUnwired. Book an online consultation for expert advice and second opinions.
Dr. Sarah Kinsley, M.D., Ph.D.
Board-Certified Oncologist & Hematologist
Dr. Sarah Kinsley is a distinguished, board-certified Medical Oncologist and Hematologist with over 15 years of experience specializing in the comprehensive treatment and compassionate care of adult patients with various solid tumor cancers and hematologic malignancies.
Focus Areas:
Breast, Lung, and Colorectal Cancer Management
Novel Immunotherapy and Targeted Therapy Protocols
Clinical Trial Enrollment and Research
Palliative Care Integration and Symptom Management
Philosophy of Care:
Dr. Kinsley believes in a patient-centered, multidisciplinary approach, ensuring that every individual receives a highly personalized treatment plan tailored to their unique diagnosis and lifestyle needs. Known for her exceptional communication skills, Dr. Kinsley is committed to fully educating patients and their families, fostering a collaborative partnership built on trust, transparency, and empathy. She is dedicated not only to achieving the best possible clinical outcomes but also to supporting the patient's emotional and psychological well-being throughout their entire journey.
Education & Training:
Medical Degree (M.D.): Harvard Medical School
Residency: Internal Medicine, Massachusetts General Hospital
Fellowship: Hematology and Oncology, Memorial Sloan Kettering Cancer Center
Ph.D.: Molecular Oncology, Yale University
Dr. Kinsley is actively involved in clinical research and has authored numerous peer-reviewed publications focusing on improving early detection markers and optimizing immunotherapy responses.
Education and Training
MSc. MBBS
Professional Experience
GMERS
Oncologiest2025-08-01 – 2025-12-04
Board-Certified Gastroenterologist & Gastrointestinal Oncologist
Dr. Alistair Vance is a dual board-certified physician specializing in Gastroenterology and Medical Oncology, focusing specifically on the diagnosis, treatment, and management of cancers affecting the digestive tract. With over 18 years of comprehensive experience, Dr. Vance integrates advanced endoscopic techniques with cutting-edge systemic therapies to provide seamless, coordinated care for patients with complex GI malignancies.
Focus Areas and Clinical Expertise:
GI Malignancies: Esophageal, gastric, pancreatic, hepatobiliary, and colorectal cancers.
Advanced Endoscopy: Diagnostic and therapeutic endoscopic procedures including EUS (Endoscopic Ultrasound) and ERCP (Endoscopic Retrograde Cholangiopancreatography) for cancer staging and symptom relief.
Systemic Therapy: Personalized chemotherapy, targeted therapies, and clinical trial enrollment for complex or advanced GI cancers.
High-Risk Screening: Management of patients with inherited syndromes and chronic conditions (like IBD or Barrett's Esophagus) that elevate the risk of GI cancer development.
GMERS
Gastroeterologist2023-01-04 – 2024-12-31
Philosophy of Care:
Dr. Vance's practice is built on the belief that early detection and aggressive, yet measured, intervention are key to survival and quality of life. He functions as a central coordinator in the patient's care journey, leveraging his expertise in both medical and procedural domains. He is dedicated to translating complex data into clear, understandable information, ensuring every patient is an informed partner in their fight against cancer.
Education & Training:
Medical Degree (M.D.): Johns Hopkins University School of Medicine
Residency: Internal Medicine, Cleveland Clinic Foundation
Fellowship I: Gastroenterology and Hepatology, Mayo Clinic
Fellowship II: Medical Oncology, M.D. Anderson Cancer Center
Academic Appointments: Clinical Assistant Professor, Saurashtra University
Dr. Vance maintains an active role in research, particularly in the areas of endoscopic staging accuracy and the efficacy of combining neoadjuvant chemotherapy with radiation for locally advanced rectal cancers.
